Cart
sales@molnova.com
HMN214
CAS No. 173529-46-9
HMN214 ( HMN214; HMN 214; HMN-214 )
Catalog No. M17370 CAS No. 173529-46-9
HMN-214(IVX214) is a potent PLK1 inhibitor with an average IC50 of 0.12 μM.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 43 | In Stock |
|
| 5MG | 69 | In Stock |
|
| 10MG | 113 | In Stock |
|
| 25MG | 207 | In Stock |
|
| 50MG | 332 | In Stock |
|
| 100MG | 478 | In Stock |
|
| 500MG | 1062 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHMN214
-
NoteResearch use only, not for human use.
-
Brief DescriptionHMN-214(IVX214) is a potent PLK1 inhibitor with an average IC50 of 0.12 μM.
-
DescriptionHMN-214 is an oral prodrug of HMN-176, a stilbene derivative that interferes with the subcellular spatial location of polo-like kinase-1, a serine/threonine kinase that regulates critical mitotic events.
-
SynonymsHMN214; HMN 214; HMN-214
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorPLK1
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number173529-46-9
-
Formula Weight424.47
-
Molecular FormulaC22H20N2O5S
-
Purity98%
-
SolubilityDMSO : 25 mg/mL 58.90 mM;
-
SMILESCC(=O)N(c1ccccc1/C=C/c1cc[n+](cc1)[O-])S(=O)(=O)c1ccc(cc1)OC
-
Chemical Name(E)-4-(2-(N-((4-methoxyphenyl)sulfonyl)acetamido)styryl)pyridine 1-oxide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Garland LL, et al. Clin Y Res. 2006 Sep 1;12(17):5182-9.
molnova catalog
related products
-
Atazanavir sulfate
A highly potent HIV-1 protease inhibitor that exhibits potent anti-HIV activity EC50 of 2.6-5.3 nM and EC90 of 9-15 nM in cell culture.
-
Dolutegravir interme...
Dolutegravir intermediate-1 is a new synthetic Dolutegravir intermediate extracted from patent WO 2016125192 A2.
-
Enfuvirtide
Enfuvirtide (INN) is an HIV fusion inhibitor, the first of a class of antiretroviral drugs used in combination therapy for the treatment of HIV-1 infection.
